Analyst Research

Report Title Price
Provider: BuySellSignals Research
$5.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: BuySellSignals Research
$5.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Department of Pharmaceuticals Rejects Drug Price Review Pleas of Dr.Reddy's Laboratories Ltd - Business Standard


Tuesday, 29 Oct 2013 08:50am EDT 

Business Standard reported that the Department of Pharmaceuticals has rejected a review petition filed by Dr.Reddy's Laboratories Ltd and Abbott Healthcare, on ceiling of prices on their products. On May 15, 2013, the Department of Pharmaceuticals released drugs (price control) order, governing the price control mechanism for 348 drugs in the national list. As per this order, the prices of each of the drugs are determined on the average of all drugs having an Indian market share of over 1% by value. The individual drug price notifications are being released in a phased manner by the National Pharmaceutical Pricing Authority. 

Company Quote

2650.0
-11.55 -0.43%
10 Jul 2014